Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
270.00    -6.00 (-2.17%)
Bid:
261.00
Ask:
272.00
Spread: 11.00 (4.215%)
Market Cap: £241.80m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Acquisition

19 Jan 2016 07:00

RNS Number : 2460M
Wilmington PLC
19 January 2016
 

 

19 January 2016

Wilmington plc

 

Acquisition of JMH Publishing Limited trading as "Wellards"

 

· Acquisition adds online education capability for the Insight knowledge area 

 

· Wellards extensive NHS knowledge base strengthens Wilmington's Healthcare offering

 

· High quality revenue streams - 70% from subscription products with over 90% renewal rates

 

Wilmington plc ("Wilmington" or "the Group"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight, announces the acquisition of JMH Publishing Ltd ("Wellards" or "the business"), a leading UK provider of specialist and accredited online education for the healthcare industry and owner of the respected trading brand "Wellards".

 

As part of Wilmington, Wellards will become the principal education and training platform for the Insight division and will benefit from Wilmington's enhanced healthcare market access, both in the UK and in mainland Europe.

 

Terms of the deal

 

Wilmington is acquiring Wellards for an initial consideration of £4.2m payable in cash. Wellards is being acquired with £1.3m of cash in its balance sheet. A final payment of up to £0.9m in March 2016 will be made once the final net current asset position has been agreed.

 

The consideration will be financed out of the Group's existing £65.0m multicurrency debt facility and is expected to be earnings enhancing in the first full year of ownership.

 

Background to Wellards

 

Wellards, established in 1990 is based in Kent, England and is managed by its founder John Heath, CEO who will remain with the business for a transitional period of one year. Wellards core online modules deliver the industry standard for effective and comprehensive NHS training and are an indispensable resource to enable understanding of the NHS and how it functions.

 

Wellards runs over 70 online courses and has more than 25,000 registered users. Subjects covered include critical areas for pharma industry representatives such as market access and financial flows, clinical modules of key therapy areas such as cancer, diabetes and cardiovascular health, ABPI code and compliance. Over 70% of its revenue is generated by its online training portal, Wellards Academy, which services the needs of UK pharmaceutical and Medtech commercial staff.

 

In the twelve month period ended 31 October 20151, revenue per the unaudited management accounts was £2.0m, an increase of 12 percent on the same period in 2014 and the adjusted profit before interest, amortisation and taxation was £0.6m1. Gross assets were 2.0m1. Wellards will provide Wilmington with an additional attractive recurring revenue stream as over 70% of its revenue is subscription based with over 90% renewal rates.

 

Acquisition rationale

 

The acquisition of Wellards is consistent with Wilmington's strategy of acquiring complementary businesses with high repeat revenues and strong, cash generative income streams in the Group's key markets. The addition of Wellards provides Wilmington with education capability for its Insight division completing the strategic objective of having information, networking and education offerings across all of Wilmington's four knowledge areas.

 

1 unaudited.

 

Commenting on the acquisition, Pedro Ros, Chief Executive Officer of Wilmington, said:

 

"I am delighted to welcome Wellards to Wilmington; its addition completes one of our strategic objectives of having information, education and networking capabilities for each of our knowledge areas. I am particularly excited by the scalability of the online products both in the broader healthcare industry and internationally where we can utilise our existing market access in particular to the French and German healthcare markets."

 

John Heath, founder and CEO of Wellards commented: 

 

"I'm delighted that Wellards is now part of Wilmington. For many years we have worked closely with Binleys; a business within Wilmington's Insight division, providing customers with the knowledge and insight needed to interpret the practical value of the Binleys resource and this acquisition is a very natural extension of our partnership.

 

I'm looking forward to developing new services which will enhance the product portfolio of both companies"

 

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Tony Foye, Chief Financial Officer

020 7422 6800

FTI Consulting

Charles Palmer

Emma Appleton

020 3727 1000

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately £225 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFVLLFQFFBBBF
Date   Source Headline
3rd Dec 20155:42 pmRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
26th Nov 20153:56 pmRNSDirector/PDMR Shareholding
10th Nov 20152:34 pmRNSHolding(s) in Company
6th Nov 201512:06 pmRNSHolding(s) in Company
5th Nov 20154:48 pmRNSResult of AGM
5th Nov 20157:00 amRNSAGM and Interim Management Statement
2nd Nov 201510:50 amRNSTotal Voting Rights
20th Oct 20156:16 pmRNSDirector/PDMR Shareholding
19th Oct 20154:03 pmRNSShare Awards
8th Oct 20154:47 pmRNSHolding(s) in Company
1st Oct 201510:24 amRNSTotal Voting Rights
25th Sep 20153:28 pmRNSHolding(s) in Company
17th Sep 20153:06 pmRNSShares Awards
15th Sep 20157:00 amRNSFinal Results
8th Sep 20157:00 amRNSBoard Changes
1st Sep 20152:19 pmRNSHolding(s) in Company
1st Sep 201512:20 pmRNSTotal Voting Rights
11th Aug 20152:00 pmRNSNotice of Results
6th Aug 20153:10 pmRNSHolding(s) in Company
3rd Aug 201511:33 amRNSTotal Voting Rights
31st Jul 20157:00 amRNSHolding(s) in Company
15th Jul 20154:42 pmRNSHolding(s) in Company
15th Jul 20157:00 amRNSHolding(s) in Company
8th Jul 201511:36 amRNSHolding(s) in Company
8th Jul 201511:30 amRNSHolding(s) in Company
7th Jul 20158:00 amRNSCapital Markets Day
7th Jul 20157:00 amRNSAcquisition of Financial Research Associates LLC
2nd Jul 201510:44 amRNSTotal Voting Rights
2nd Jul 20157:00 amRNSExtension of Debt Facility
2nd Jun 20159:19 amRNSPDMR Share Purchase
1st Jun 20153:08 pmRNSTotal Voting Rights
6th May 20157:01 amRNSInterim Management Statement
1st May 201510:14 amRNSTotal Voting Rights
1st Apr 201510:25 amRNSTotal Voting Rights
25th Mar 20154:44 pmRNSHolding(s) in Company
2nd Mar 201510:40 amRNSVoting Rights
27th Feb 20159:16 amRNSChange of Name
25th Feb 201511:58 amRNSShareholding Announcement
25th Feb 20157:01 amRNSHalf Year Results
19th Feb 20159:33 amRNSHolding(s) in Company
3rd Feb 20154:40 pmRNSTotal Voting Rights
26th Jan 201510:14 amRNSHolding(s) in Company
23rd Jan 20153:12 pmRNSHolding(s) in Company
23rd Jan 20151:59 pmRNSHolding(s) in Company
22nd Jan 201510:03 amRNSHolding(s) in Company
14th Jan 20153:54 pmRNSNotice of Results
5th Jan 20157:00 amRNSVoting Rights and Capital
10th Dec 20147:01 amRNSBoard Change
10th Dec 20147:00 amRNSInterim Update on Business Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.